(AXSM) Axsome Therapeutics - Performance 59% in 12m
Compare AXSM with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
44.35%
#25 in Group
Rel. Strength
92.36%
#611 in Universe
Total Return 12m
58.95%
#16 in Group
Total Return 5y
50.15%
#31 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -2.62%
17th Percentile in Group
12m Total Return: AXSM (59%) vs XLV (-0.5%)

5y Drawdown (Underwater) Chart

Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
CORT NASDAQ Corcept Therapeutics |
10.2% | 175% | 405% | 55.8 | 41 | 0.61 | 61.4% | 10.7% |
LLY NYSE Eli Lilly |
2.12% | 13.3% | 466% | 62.7 | 31.5 | 1.05 | 40.3% | 34.5% |
NVS NYSE Novartis |
-1.21% | 24.1% | 59.8% | 18 | 12.9 | 1.23 | 36.2% | 11% |
SFZN SW Siegfried Holding |
-2.09% | 1.78% | 95.3% | 24.1 | 22.1 | 1.41 | 66.7% | 72.5% |
SUPN NASDAQ Supernus Pharmaceuticals |
-4.71% | 6.55% | 74.3% | 24 | 20.2 | 1.47 | -20.8% | -17% |
SOBI ST Swedish Orphan Biovitrum |
-8.43% | 1.39% | 42.8% | 23.3 | 18.7 | 1.44 | 11.8% | 14.7% |
SAN PA Sanofi |
-15.7% | 10.9% | 24.2% | 21.9 | 11.6 | 0.93 | -22.1% | -24.8% |
NOVN SW Novartis |
-7.92% | 11.1% | 33.1% | 17.9 | 12.8 | 1.22 | 36.2% | 11.2% |
Performance Comparison: AXSM vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for AXSM
Total Return (including Dividends) | AXSM | XLV | S&P 500 |
---|---|---|---|
1 Month | -16.27% | -7.37% | -5.89% |
3 Months | 8.61% | -4.55% | -12.45% |
12 Months | 58.95% | -0.54% | 6.72% |
5 Years | 50.15% | 46.59% | 101.06% |
Trend Score (consistency of price movement) | AXSM | XLV | S&P 500 |
1 Month | -81.0% | -82.6% | -74.5% |
3 Months | -11.5% | -37.8% | -88.2% |
12 Months | 88.6% | -1.6% | 66.1% |
5 Years | 44.2% | 90.1% | 84.3% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
1 Month | #125 | -9.61% | -11.0% |
3 Month | #22 | 13.8% | 24.1% |
12 Month | #16 | 59.8% | 48.9% |
5 Years | #32 | 2.43% | -25.3% |
FAQs
Does AXSM Axsome Therapeutics outperforms the market?
Yes,
over the last 12 months AXSM made 58.95%, while its related Sector, the Health Care Sector SPDR (XLV) made -0.54%.
Over the last 3 months AXSM made 8.61%, while XLV made -4.55%.
Over the last 3 months AXSM made 8.61%, while XLV made -4.55%.
Performance Comparison AXSM vs Indeces and Sectors
AXSM vs. Indices AXSM is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 7.94% | -10.4% | 21.3% | 52.2% |
US NASDAQ 100 | QQQ | 8.80% | -9.99% | 21.8% | 53.4% |
US Dow Jones Industrial 30 | DIA | 9.11% | -10.5% | 20.7% | 53.6% |
German DAX 40 | DAX | 2.58% | -6.87% | 4.22% | 40.7% |
Shanghai Shenzhen CSI 300 | CSI 300 | 7.23% | -8.77% | 19.0% | 53.1% |
Hongkong Hang Seng | HSI | 3.65% | -6.45% | 19.8% | 42.7% |
India NIFTY 50 | INDA | 3.57% | -21.0% | 18.8% | 55.9% |
Brasil Bovespa | EWZ | 4.38% | -11.2% | 18.3% | 68.4% |
AXSM vs. Sectors AXSM is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 7.69% | -10.6% | 12.5% | 45.4% |
Consumer Discretionary | XLY | 8.81% | -12.4% | 18.5% | 49.7% |
Consumer Staples | XLP | 4.64% | -19.5% | 11.1% | 45.0% |
Energy | XLE | 3.22% | -6.19% | 20.2% | 69.2% |
Financial | XLF | 6.57% | -11.8% | 13.2% | 40.0% |
Health Care | XLV | 7.54% | -8.90% | 22.7% | 59.5% |
Industrial | XLI | 6.82% | -11.6% | 21.2% | 53.6% |
Materials | XLB | 6.22% | -9.62% | 28.4% | 66.5% |
Real Estate | XLRE | 2.60% | -13.4% | 19.9% | 41.8% |
Technology | XLK | 9.30% | -7.34% | 28.1% | 60.2% |
Utilities | XLU | 4.63% | -15.9% | 15.5% | 34.6% |
Aerospace & Defense | XAR | 6.25% | -16.3% | 11.5% | 34.8% |
Biotech | XBI | 4.38% | -4.39% | 35.8% | 67.9% |
Homebuilder | XHB | 6.99% | -9.43% | 39.2% | 68.1% |
Retail | XRT | 6.24% | -14.2% | 26.0% | 63.3% |